Next report date
Report period
H2 2023
EPS estimate
—
Revenue estimate
—
0.180EUR
52.40 MEUR
1.54 BEUR
167.59 M
About OVS
Sector
Industry
CEO
Stefano Beraldo
Website
Headquarters
Mestre
Founded
2014
ISIN
IT0005043507
FIGI
BBG00DWWJ8G0
OVS SpA engages in the creation, development and marketing of clothing & accessories for men, women, and children. It operates through the two segments: OVS and UPIM. The OVS segment carries apparel of the same brand name that is designed according to the latest fashion trends. The UPIM segment offers a range of clothing, cosmetics, and home accessories of the same brand name that targets the family clientele. The company was founded in 1972 and is headquartered in Mestre, Italy.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0R5R is 2.502 EUR — it has increased by 0.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange OVS SPA NPV stocks are traded under the ticker 0R5R.
OVS SPA NPV is going to release the next earnings report on Apr 17, 2024. Keep track of upcoming events with our Earnings Calendar.
0R5R stock is 1.78% volatile and has beta coefficient of 1.01. Check out the list of the most volatile stocks — is OVS SPA NPV there?
0R5R earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.10 EUR resulting in a −27.27% surprise. The estimated earnings for the next quarter are 0.17 EUR per share. See more details about OVS SPA NPV earnings.
OVS SPA NPV revenue for the last quarter amounts to 375.70 M EUR despite the estimated figure of 423.19 M EUR. In the next quarter revenue is expected to reach 533.58 M EUR.
Yes, you can track OVS SPA NPV financials in yearly and quarterly reports right on TradingView.
0R5R stock has risen by 4.25% compared to the previous week, the month change is a 6.47% rise, over the last year OVS SPA NPV has showed a 8.00% decrease.
0R5R net income for the last quarter is 30.02 M EUR, while the quarter before that showed 22.26 M EUR of net income which accounts for 34.88% change. Track more OVS SPA NPV financial stats to get the full picture.
Today OVS SPA NPV has the market capitalization of 677.65 M, it has increased by 12.81% over the last week.
OVS SPA NPV dividend yield was 1.36% in 2023, and payout ratio reached 16.66%. The year before the numbers were 2.72% and 43.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0R5R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OVS SPA NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OVS SPA NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OVS SPA NPV stock shows the buy signal. See more of OVS SPA NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OVS SPA NPV future price: according to them, 0R5R price has a max estimate of 4.50 EUR and a min estimate of 3.10 EUR. Read a more detailed OVS SPA NPV forecast: see what analysts think of OVS SPA NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OVS SPA NPV EBITDA is 226.05 M EUR, and current EBITDA margin is 19.83%. See more stats in OVS SPA NPV financial statements.